Oral β-lactams in the treatment of acute bacterial rhinosinusitis
- 31 March 2007
- journal article
- review article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 57 (3), S47-S54
- https://doi.org/10.1016/j.diagmicrobio.2006.11.018
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999–2003)Diagnostic Microbiology and Infectious Disease, 2006
- Cefdinir: An oral alternative to parenteral cephemsDiagnostic Microbiology and Infectious Disease, 2005
- Patterns of health care resource utilization after macrolide treatment failure: Results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumoniaClinical Therapeutics, 2004
- Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: A multicenter, randomized, double-blind studyClinical Therapeutics, 2004
- Acute Community-Acquired Bacterial Sinusitis: Continuing Challenges and Current ManagementClinical Infectious Diseases, 2004
- CefdinirDrugs, 2004
- Management update of acute bacterial rhinosinusitis and the use of cefdinirOtolaryngology -- Head and Neck Surgery, 2002
- Rigid Nasal Endoscopy versus Sinus Puncture and Aspiration for Microbiologic Documentation of Acute Bacterial Maxillary SinusitisClinical Infectious Diseases, 2001
- Comparison of moxifloxacin and cefuroxime axetil in the treatment of acute maxillary sinusitisClinical Therapeutics, 1999
- Multicenter comparative trial of ciprofloxacin versus cefuroxime axetil in the treatment of acute rhinosinusitis in a primary care settingClinical Therapeutics, 1998